Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...

Scientists at Johns Hopkins Medicine say they have discovered how a group of proteins linked to Parkinson's disease and ...

Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show g ...

SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...

Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for ...

As Oklahoma lawmakers consider House Bill 1278, which aims to fund research and care for those battling Amyotrophic Lateral ...

Previous mouse studies have shown that, when conditions in cells are normal, removing, or “knocking out,” any one of the ...

Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer's pTau217 pathology ...

The first study participant was enrolled in July 2024, and since that time, the consortium has recruited over 300 participants.

In Huntington’s disease, a genetic error leads the protein huntingtin to form clumps in the brain, leading to involuntary ...

She doesn't want to spend time fighting with her health insurer. After all, she's terminally ill. However, she said she ...